Research Triangle Park, NC (October 15, 2015)...Ed Addison, CEO of Cloud Pharmaceuticals Inc., a cloud-based drug design and development company, is being featured as a presenter at the Cavendish Global Health Impact Forum taking place October 25 to 28, 2015 at The Cleveland Clinic. Addison will discuss how computer-based drug design is helping to enable a transformation in the pharmaceutical industry, especially related to the design and development of new medicines for challenging indications.
During his session, Addison will provide an overview of new developments and partnerships the company has established to apply cloud computing and computational chemistry to drug design and development processes. He will describe Cloud Pharmaceuticals’ work with companies such as Perthera to target pancreatic cancer, Genomeon to drug novel targets, and THERAMetrics focusing on Alzheimer’s and ALS. He will answer questions such as:
• How do we develop new medicines for the most challenging diseases?
• What will be the next generation of drug discovery in an industry that’s struggling to stay profitable?
• How does the digital revolution and genomics create new opportunities for human health?
Michael Moffat, Cavendish co-founder and Chief Executive Officer explains, “The theme of our Cleveland Clinic hosted Forum is a ‘Celebration of Philanthropy, Impact Investing and Innovation that is Changing the World.’ With the help of our expert advisors, we conduct a global search of research institutions and private-sector companies to identify organizations that meet our standards of excellence. The quality and originality of Cloud Pharmaceuticals’ work makes them a natural fit for our audience.”
Addison adds, “Cloud Pharmaceuticals’ mission is to improve health and well-being through the rapid design and efficient development of new medicines. We’re honored to have an opportunity to share our mission at this event. We welcome the chance to interact with accomplished scientists, thought leaders, and philanthropic individuals and families who are all dedicated to the common cause of improving the health and lives of people around the world.”
About Cavendish Global
Cavendish Global provides family offices and their foundations with a discrete, peer-to-peer knowledge expansion and relationship building environment, combined with the innovative resources required to help develop and implement their individual pro-social impact investment and philanthropy programs within health and the life sciences. Cavendish Global provides family offices with a number of innovative resources, which includes Cavendish Impact Forums. A unique gathering of leading family offices, Cavendish Impact Forums take place three times each year; the next Forum is being co-hosted by The Cleveland Clinic and Cleveland Clinic Innovations. For more information visit www.cavendishglobal.com
About Cloud Pharmaceuticals, Inc.
Cloud Pharmaceuticals is committed to improving health and well-being through the computational design and rapid development of new medicines. Its Quantum Molecular Design process designs drug candidates that are qualified for development from the outset, enabling faster progress at lower cost and a higher success rate. The company partners at all stages of drug development – from discovery through the clinic – and is building an extensive product pipeline that spans a wide range of indications. For information visit www.cloudpharmaceuticals.com
Help employers find you! Check out all the jobs and post your resume.
